Evidence map›Paper›PMID 33970338›Full record

ArticleJournal of neurology2021

Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis.

Silvia Tommasin, Sirio Cocozza, Alessandro Taloni, Costanza Giannì, Nikolaos Petsas, Giuseppe Pontillo, Maria Petracca, Serena Ruggieri, Laura De Giglio, Carlo Pozzilli and 2 more

Abstract read
In one paragraph

Article in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Semi-Supervised Learning for Predicting Multiple Sclerosis.Journal of personalized medicine · 2025
    Article
  7. Article
  8. Review
  9. Time-Dependent Deep Learning Prediction of Multiple Sclerosis Disability.Journal of imaging informatics in medicine · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Silvia TommasinDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, 00185, Rome, Italy. silvia.tommasin@uniroma1.it.ORCID http://orcid.org/0000-0001-9088-7968
Sirio CocozzaDipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II, Naples, Italy.ORCID http://orcid.org/0000-0002-0300-5160
Alessandro TaloniInstitute for Complex Systems, Italian National Research Council, Rome, Italy.ORCID http://orcid.org/0000-0002-8863-7166
Costanza GiannìDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, 00185, Rome, Italy.ORCID http://orcid.org/0000-0002-4018-169X
Nikolaos PetsasDepartment of Radiology, IRCCS NEUROMED, Pozzilli, Italy.ORCID http://orcid.org/0000-0001-7150-9697
Giuseppe PontilloDipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II, Naples, Italy.ORCID http://orcid.org/0000-0001-5425-1890
Maria PetraccaDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, 00185, Rome, Italy.ORCID http://orcid.org/0000-0001-9429-2769
Serena RuggieriDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, 00185, Rome, Italy.ORCID http://orcid.org/0000-0001-5287-3290
Laura De GiglioDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, 00185, Rome, Italy.ORCID http://orcid.org/0000-0001-9018-7320
Carlo PozzilliDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, 00185, Rome, Italy.ORCID http://orcid.org/0000-0002-6360-4798
Arturo BrunettiDipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II, Naples, Italy.ORCID http://orcid.org/0000-0001-7057-3494
Patrizia PantanoDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, 00185, Rome, Italy.ORCID http://orcid.org/0000-0001-9659-8294

Funding

Fondazione Italiana Sclerosi Multipla FISM/2018/S/3
6 · The paper itself

Abstract

objectivesTo evaluate the accuracy of a data-driven approach, such as machine learning classification, in predicting disability progression in MS.

methodsWe analyzed structural brain images of 163 subjects diagnosed with MS acquired at two different sites. Participants were followed up for 2-6 years, with disability progression defined according to the expanded disability status scale (EDSS) increment at follow-up. T2-weighted lesion load (T2LL), thalamic and cerebellar gray matter (GM) volumes, fractional anisotropy of the normal appearing white matter were calculated at baseline and included in supervised machine learning classifiers. Age, sex, phenotype, EDSS at baseline, therapy and time to follow-up period were also included. Classes were labeled as stable or progressed disability. Participants were randomly chosen from both sites to build a sample including 50% patients showing disability progression and 50% patients being stable. One-thousand machine learning classifiers were applied to the resulting sample, and after testing for overfitting, classifier confusion matrix, relative metrics and feature importance were evaluated.

resultsAt follow-up, 36% of participants showed disability progression. The classifier with the highest resulting metrics had accuracy of 0.79, area under the true positive versus false positive rates curve of 0.81, sensitivity of 0.90 and specificity of 0.71. T2LL, thalamic volume, disability at baseline and administered therapy were identified as important features in predicting disability progression. Classifiers built on radiological features had higher accuracy than those built on clinical features.

conclusionsDisability progression in MS may be predicted via machine learning classifiers, mostly evaluating neuroradiological features.

Indexed as

Multiple SclerosisBrainDisability EvaluationDisease ProgressionGray MatterHumansMachine LearningMagnetic Resonance ImagingDisability progressionMachine learningMagnetic resonance imagingMultiple sclerosis

Identifiers

PMID33970338
PMCPMC8563671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.